From: Clinical image quality perception and its relation to NECR measurements in PET
Value | |
---|---|
Number of patients | 71 |
Pathologic lesion, n (%) | |
Yes | 42 (59.2) |
No | 29 (40.8) |
Indication, n (%) | |
Primary staging | 16 (22.5) |
Follow-up/re-staging | 53 (74.6) |
Non-oncological (FUO and aortic aneurysm graft) | 2 (2.8) |
Tumour type, n | |
Lymphoma (NHL/HD) | 18 (11/7) |
Lung cancer (proved/suspicious/incidental) | 13 (10/2/1) |
Breast cancer | 9 |
Melanoma | 7 |
Renal cell | 3 |
Oesophagus, larynx, stomach | 2 |
Adrenal, anal, colon, fibrosarcoma, follicular thyroid, hypopharynx, nasopharynx, oropharynx, ovarian, paraganglioma, myeloid sarcoma, mesothelioma, rectal, SCC right upper arm | 1 |
Under therapy, n (%) | |
Yes | 13 (18.3) |
No | 56 (78.9) |
N/A | 2 (2.8) |